Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database A
about
Considerations for observational research using large data sets in radiation oncologyAngiotensin receptor blockers and risk of prostate cancer among United States veteransStandards should be applied in the prevention and handling of missing data for patient-centered outcomes research: a systematic review and expert consensus.Clinical research informatics and electronic health record dataEconomic and clinical benefits of radiofrequency ablation versus hysterectomy in patients suffering from menorrhagia: a retrospective analysis with German health claims data.Economic and clinical benefits of endometrial radiofrequency ablation compared with other ablation techniques in women with menorrhagia: a retrospective analysis with German health claims data.Agreement of treatment effects for mortality from routinely collected data and subsequent randomized trials: meta-epidemiological surveyUSING CLAIMS DATA FOR EVIDENCE GENERATION IN MANAGED ENTRY AGREEMENTS."A Bayesian sensitivity analysis to evaluate the impact of unmeasured confounding with external data: a real world comparative effectiveness study in osteoporosis".Current use of routinely collected health data to complement randomized controlled trials: a meta-epidemiological survey.A General Framework for Considering Selection Bias in EHR-Based Studies: What Data Are Observed and Why?A bias-adjusted evidence synthesis of RCT and observational data: the case of total hip replacement.Effect of candesartan monotherapy on lipid metabolism in patients with hypertension: a retrospective longitudinal survey using data from electronic medical records.A Comparative Effectiveness Study of Renal Parameters Between Imidapril and Amlodipine in Patients with Hypertension: A Retrospective Cohort StudyImpact of Nonadherence to Inhaled Corticosteroid/LABA Therapy on COPD Exacerbation Rates and Healthcare Costs in a Commercially Insured US Population.A model for incorporating patient and stakeholder voices in a learning health care network: Washington State's Comparative Effectiveness Research Translation Network.The use and effectiveness of rituximab maintenance in patients with follicular lymphoma diagnosed between 2004 and 2007 in the United States.Racial variation in the cost-effectiveness of chemotherapy for prostate cancer.Computer disease simulation models: integrating evidence for health policy.A review of causal inference for biomedical informatics.Concepts of 'personalization' in personalized medicine: implications for economic evaluation.Real World Data in Adaptive Biomedical Innovation: A Framework for Generating Evidence Fit for Decision-Making.A Systematic Review and Meta-Analysis of the Data Behind Current Recommendations for Corticosteroids in Non-HIV-Related PCP: Knowing When You Are on Shaky Foundations.Cardiovascular risk in rheumatoid arthritis: comparing TNF-α blockade with nonbiologic DMARDsEvaluation of Healthcare Interventions and Big Data: Review of Associated Data Issues.Will electronic health record data become the standard resource for clinical research?Preeclampsia prevention: a case-control study nested in a cohort.Epidemiologic and statistical methods for comparative effectiveness research.Measurement in comparative effectiveness research.IDEAL framework for surgical innovation 2: observational studies in the exploration and assessment stages.Economic evaluation of vaccines in Canada: A systematic review.Marginal structural models for skewed outcomes: identifying causal relationships in health care utilization.Comparison of health utility weights among elderly patients receiving breast-conserving surgery plus hormonal therapy with or without radiotherapy.Comparative effectiveness of individual angiotensin receptor blockers on risk of mortality in patients with chronic heart failure.Utilization of health care databases for pharmacoepidemiology.Evaluating methodological assumptions in comparative effectiveness research: overcoming pitfalls.Blood utilization and hemoglobin levels in cancer patients after label and coverage changes for erythropoiesis-stimulating agents.Comparative effectiveness of colony-stimulating factors in febrile neutropenia prophylaxis: how results are affected by research design.Bladder antimuscarinics and cognitive decline in elderly patients.Real-world research and the role of observational data in the field of gynaecology - a practical review.
P2860
Q24289442-B35C29DA-DD2B-4A57-9192-127B9C31DC1FQ24626548-E01A2100-F696-44D0-9984-268D535B1A9FQ30699551-FB45A6C3-18C2-41D1-BD04-6A9A4D346146Q30842819-F3C0DB96-3CFA-4AEB-8E0C-0A1440EF05E2Q30897322-CFAF175D-AF1E-4E32-A9E7-9EBF5F745A31Q31043178-0DD16E71-43B5-4E4F-B78F-922EE7189F80Q31043715-8E5244CE-44E2-4DA6-9AF8-DF55F648A926Q31058117-768CF349-2FED-430B-BC23-A70190B1AAB6Q31113647-D23895F6-8D8C-4DE9-B239-9346B3C64708Q31113747-4C8161BF-8BF3-4C24-B8C0-AD87EF66F919Q31133096-84905A31-6A69-49BC-B04F-996FE35C8731Q31158042-C4491812-38F8-4332-899B-81C01941015EQ33659515-B2CBB261-F2E8-4288-841C-A45498F6253EQ33734015-31988D67-60F0-495D-9591-FE9B63538F4BQ33795984-4AD48E08-8C5A-489E-B8D6-62F84CC5D2A6Q33901024-E1238B0E-DFF7-40C7-AA3F-666FE9496431Q34699650-6B9CF0F7-468A-4620-9CA3-A748C92CA628Q34974133-2A28B014-166D-475F-9029-96E6449ECBEFQ35074556-DBF30D15-2765-466E-9738-B13AE9A81B01Q35560716-760A6DDF-6209-4812-99F6-3F8E13E09D22Q35575935-CF35D878-1F0F-497E-89F4-803BB77C6956Q36132510-82F465F6-8B58-456C-B14A-642A08AFF785Q36329163-46CB2E9D-C54D-43CC-861A-B1516BCAD80DQ36361147-64F20C1F-1AF0-4B2C-A286-A7128BA89D9FQ36363886-157DFFE5-6AA8-4D3E-B50D-93DB6AE4B9AEQ36410572-A259E275-B689-4F55-8012-8F602FA171BCQ36519271-92A3C23D-D8EA-4DC2-94DB-EEC058ADF4ECQ36660279-F095ABA9-3017-48EC-AB7F-234FA83B1489Q36781581-5CB6A510-8256-46C4-99BA-DEFC52135354Q36937313-7CC3C8D7-8E29-45E2-9879-46AD55F0BEBFQ37131005-FAAB7663-E4B4-46AA-81C9-624E34418FF2Q37685128-1C4C6AF1-2343-464C-A71D-157B8D7A62E1Q37691807-AD02DBC8-367B-4416-8EE6-D5EEFA7F644EQ37904934-2183C906-F76E-4FCB-AB66-4E1A59018BA4Q37910015-3E6AEB83-43D8-4ACA-BEAE-063178324E50Q38171873-3DE8D2CC-5FF5-4F71-9C34-96D87DE2BA7FQ38235807-7FF699FD-0220-49F6-A96D-7DBFFCD9E289Q38309710-2A38884B-D497-4CD9-B657-A939DEDE184CQ38377308-B5E5541D-6D63-4B43-96CB-AEF3579E0E97Q38619701-04A596E9-7CDA-414D-B052-04DBA3B0E76A
P2860
Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database A
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Good research practices for co ...... s for Retrospective Database A
@ast
Good research practices for co ...... s for Retrospective Database A
@en
type
label
Good research practices for co ...... s for Retrospective Database A
@ast
Good research practices for co ...... s for Retrospective Database A
@en
prefLabel
Good research practices for co ...... s for Retrospective Database A
@ast
Good research practices for co ...... s for Retrospective Database A
@en
P2093
P1433
P1476
Good research practices for co ...... s for Retrospective Database A
@en
P2093
Bradley C Martin
Michael L Johnson
Uwe Siebert
William Crown
P304
P356
10.1111/J.1524-4733.2009.00602.X
P577
2009-09-29T00:00:00Z